Estimates of outcome
| Time point and outcome measure | Intervention (N=132) Mean (SD) | Control (N=150) Mean (SD) | Adjusted difference** | 95% CI | P value |
| Baseline HowRThey | 4.96 (2.87) | 4.55 (3.20) | |||
| HowRwe | 8.76 (2.38) | 9.11 (2.23) | |||
| EQ-5D—patient | 0.24 (0.37) | 0.32 (0.36) | |||
| EQ-5D—SI | 0.80 (0.24) | 0.85 (0.23) | |||
| EQ-5D—proxy | −0.01 (0.23) | 0.15 (0.33) | |||
| MMSE | 12.2 (8.0) | 10.8 (8.8) | |||
| BADLS | 24.3 (14.0) | 21.0 (14.7) | |||
| 4AT | 4.02 (3.33) | 4.80 (4.02) | |||
| CDR | 1.63 (0.98) | 1.41 (0.95) | |||
| Discharge | |||||
| 4AT | 3.1 (2.7) | 3.9 (3.4) | −0.45 | (−1.23 to 0.33) | 0.255 |
| HowRThey | 3.3 (2.8) | 2.5 (2.8) | 0.52 | (−0.65 to 1.69) | 0.387 |
| HowRwe | 8.9 (2.5) | 9.1 (2.4) | −0.35 | (−1.15 to 0.44) | 0.387 |
| Length of stay | 18.8 (10.2) | 16.6 (12.0) | 2.15 | (−0.70 to 5.01) | 0.139 |
| PERFECTER | 0.75 (0.11) | 0.74 (0.17) | 0.059 | (−0.10 to 0.21) | 0.450 |
| 1 month | |||||
| BADLS | 25.0 (12.5) | 24.8 (13.6) | −1.50 | (−4.56 to 1.57) | 0.338 |
| EQ-5D SI | 0.8 (0.2) | 0.9 (0.2) | −0.029 | (−0.066 to 0.007) | 0.113 |
| EQ-5D by Proxy | 0.2 (0.3) | 0.3 (0.3) | 0.028 | (−0.042 to 0.099) | 0.434 |
| EQ-5D Patient | 0.6 (0.3) | 0.5 (0.4) | 0.074 | (−0.078 to 0.225) | 0.341 |
| HowRThey | 4.8 (2.6) | 4.0 (2.8) | 0.601 | (−0.040 to 1.241) | 0.066 |
| MMSE | 13.9 (8.0) | 13.0 (7.9) | 0.29 | (−1.04 to 1.62) | 0.669 |
| 3 months | |||||
| BADLS | 24.6 (13.6) | 22.4 (13.4) | −0.46 | (−4.35 to 3.42) | 0.815 |
| EQ-5D SI | 0.8 (0.2) | 0.9 (0.2) | −0.017 | (−0.073 to 0.039) | 0.556 |
| EQ-5D Proxy | 0.3 (0.3) | 0.3 (0.3) | 0.071 | (0.018 to 0.124) | 0.009 |
| EQ-5D Patient | 0.6 (0.3) | 0.6 (0.4) | 0.024 | (−0.052 to 0.101) | 0.533 |
| HowRThey | 4.3 (2.5) | 3.4 (2.9) | 0.47 | (−0.53 to 1.47) | 0.359 |
| MMSE | 13.6 (8.6) | 12.5 (8.9) | 0.75 | (−0.77 to 2.27) | 0.333 |
| Timed Up and Go | 47.3 (33.3) | 48.7 (28.1) | −1.54 | (−15.38 to 12.30) | 0.827 |
| 6 months | |||||
| BADLS | 26.4 (14.2) | 21.6 (12.0) | 1.97 | (−1.31 to 5.25) | 0.239 |
| CDR Score (SI) | 1.9 (1.1) | 1.7 (1.0) | −0.015 | (−0.160 to 0.131) | 0.845 |
| EQ-5D SI | 0.8 (0.2) | 0.9 (0.2) | −0.016 | (−0.096 to 0.063) | 0.688 |
| EQ-5D by Proxy | 0.4 (0.3) | 0.3 (0.4) | 0.099 | (0.001 to 0.198) | 0.047 |
| EQ-5D Patient | 0.7 (0.3) | 0.7 (0.3) | 0.057 | (−0.104 to 0.218) | 0.489 |
| HowRThey | 4.1 (2.7) | 3.3 (2.7) | 0.38 | (−0.49 to 1.25) | 0.394 |
| MMSE | 13.1 (9.3) | 12.2 (8.9) | 0.69 | (−1.14 to 2.53) | 0.457 |
*a: Estimated from a general linear model using generalised estimating equations. This model includes the baseline value of the modelled outcome where available.
BADLS, Bristol Activities of Daily Living Score; CDR, Clinical Dementia Rating.